BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

517 related articles for article (PubMed ID: 7655870)

  • 1. Rheumatic manifestations at presentation of Hodgkin's disease and non-Hodgkin's malignant lymphoma. A national survey of one hundred forty-six patients.
    Gaudin P; Rozand Y; Fauconnier J; Phelip X
    Rev Rhum Engl Ed; 1995 May; 62(5):365-75. PubMed ID: 7655870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hodgkin's and non-Hodgkin's lymphoma of the head and neck.
    Urquhart A; Berg R
    Laryngoscope; 2001 Sep; 111(9):1565-9. PubMed ID: 11568605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malignant lymphoma in western Ethiopia.
    Getachew A
    East Afr Med J; 2001 Aug; 78(8):402-4. PubMed ID: 11921560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malignant lymphoma-associated autoimmune diseases--a descriptive epidemiological study.
    Váróczy L; Gergely L; Zeher M; Szegedi G; Illés A
    Rheumatol Int; 2002 Nov; 22(6):233-7. PubMed ID: 12426661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hodgkin's lymphoma presenting as extradural spinal cord compression.
    Paul TR; Sundaram C; Reddy AK
    J Assoc Physicians India; 2003 Oct; 51():960-2. PubMed ID: 14719584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Lymphoid depletion type 4 Hodgkin disease. Anatomoclinical review of 35 cases].
    Eghbali H; Pétorin C; de Mascarel I; Trojani M; Hoerni-Simon G; Soubeyran P; Hoerni B
    Bull Cancer; 1994 Oct; 81(10):866-70. PubMed ID: 7734769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Respiratory manifestations of malignant lymphomas: report of 5 cases].
    Ndiaye M; Hane AA; Diop AK; Ndir M; Ba O; Diop-Dia D; Kandji M; Diatta A; Ndiaye S; Toure NO; Dia Y; Niang A; Badiane M; Mendes V; Thiam D
    Dakar Med; 2001; 46(1):32-5. PubMed ID: 15773153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Bone manifestations disclosing Hodgkin's disease and non-Hodgkin's malignant lymphoma. Analysis of 11 cases].
    Gaudin P; Troussier B; Zagala A; Pillon P; Rose-Pittet L; Le Bas JF; Pegourie B; Phelip X
    Rev Rhum Mal Osteoartic; 1989 Nov; 56(11):745-51. PubMed ID: 2609087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [ORL manifestations in malignant hemopathies].
    Koffi-Aka V; Akon JC; Koné M; Yotio A; Ehouo F
    Rev Laryngol Otol Rhinol (Bord); 1999; 120(2):97-101. PubMed ID: 10444982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic lupus erythematosus and Hodgkin's lymphoma.
    Bhalla R; Ajmani HS; Kim WW; Swedler WI; Lazarevic MB; Skosey JL
    J Rheumatol; 1993 Aug; 20(8):1316-20. PubMed ID: 8230011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cutaneous manifestations of Hodgkin's disease.
    Rubenstein M; Duvic M
    Int J Dermatol; 2006 Mar; 45(3):251-6. PubMed ID: 16533224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mediastinal Hodgkin's disease and non-Hodgkin lymphoma in childhood].
    Kuleva SA
    Vopr Onkol; 2002; 48(6):735-7. PubMed ID: 12530278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-barr virus-associated non-Hodgkin's lymphoma of B-cell origin, Hodgkin's disease, acute leukemia, and systemic lupus erythematosus: a serologic and molecular analysis.
    Mitarnun W; Pradutkanchana J; Takao S; Saechan V; Suwiwat S; Ishida T
    J Med Assoc Thai; 2002 May; 85(5):552-9. PubMed ID: 12188384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma].
    Fu XH; Wang SS; Huang Y; Wang B; Huang HQ; Zhang L; Sun XF; Xu RH; Lin TY
    Ai Zheng; 2006 Aug; 25(8):1013-8. PubMed ID: 16965685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum CA 125 is of clinical value in the staging and follow-up of patients with non-Hodgkin's lymphoma: correlation with tumor parameters and disease activity.
    Lazzarino M; Orlandi E; Klersy C; Astori C; Brusamolino E; Corso A; Bellio L; Gargantini L; Morra E; Bernasconi C
    Cancer; 1998 Feb; 82(3):576-82. PubMed ID: 9452277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High prevalence of hepatitis B virus infection in patients with B-cell non-Hodgkin's lymphoma in Korea.
    Park SC; Jeong SH; Kim J; Han CJ; Kim YC; Choi KS; Cho JH; Lee M; Jung HH; Ki SS; Chang YH; Lee SS; Park YH; Lee KH
    J Med Virol; 2008 Jun; 80(6):960-6. PubMed ID: 18428141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longer failure-free survival interval of Epstein-Barr virus-associated classical Hodgkin's lymphoma: a single-institution study.
    Krugmann J; Tzankov A; Gschwendtner A; Fischhofer M; Greil R; Fend F; Dirnhofer S
    Mod Pathol; 2003 Jun; 16(6):566-73. PubMed ID: 12808062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Misdiagnosis of malignant lymphoma--report of 45 patients].
    Wang PY; Gao YF; Tong WX; Zhang YH; Jia L; Yang R
    Zhonghua Zhong Liu Za Zhi; 1987 Nov; 9(6):439-41. PubMed ID: 3452541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-Hodgkin's lymphoma and family history of hematologic malignancy.
    Mensah FK; Willett EV; Ansell P; Adamson PJ; Roman E
    Am J Epidemiol; 2007 Jan; 165(2):126-33. PubMed ID: 17071845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum interleukin 6 levels are elevated in lymphoma patients and correlate with survival in advanced Hodgkin's disease and with B symptoms.
    Kurzrock R; Redman J; Cabanillas F; Jones D; Rothberg J; Talpaz M
    Cancer Res; 1993 May; 53(9):2118-22. PubMed ID: 8481913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.